2.62
price up icon5.22%   0.13
after-market 시간 외 거래: 2.60 -0.02 -0.76%
loading

2 Seventy Bio Inc 주식(TSVT)의 최신 뉴스

pulisher
Jan 24, 2025

Layoff Tracker: Biogen to Cut Undisclosed Number of Research Employees - BioSpace

Jan 24, 2025
pulisher
Jan 20, 2025

Weiss Ratings Reaffirms “Sell (E+)” Rating for 2seventy bio (NASDAQ:TSVT) - Defense World

Jan 20, 2025
pulisher
Jan 04, 2025

Barclays PLC Sells 132,019 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Jan 04, 2025
pulisher
Dec 18, 2024

Fmr LLC Has $701,000 Stock Holdings in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Dec 18, 2024
pulisher
Nov 15, 2024

Analysts Have Been Trimming Their 2seventy bio, Inc. (NASDAQ:TSVT) Price Target After Its Latest Report - Simply Wall St

Nov 15, 2024
pulisher
Nov 12, 2024

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress - Business Wire

Nov 12, 2024
pulisher
Nov 06, 2024

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results - GlobeNewswire

Nov 06, 2024
pulisher
Nov 04, 2024

2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference - Business Wire

Nov 04, 2024
pulisher
Oct 22, 2024

2seventy bio, Inc. (NASDAQ:TSVT) Shares Sold by Exchange Traded Concepts LLC - Defense World

Oct 22, 2024
pulisher
Oct 17, 2024

BioAegis Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS) - Yahoo Finance

Oct 17, 2024
pulisher
Oct 14, 2024

Dimensional Fund Advisors LP Sells 24,371 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Oct 14, 2024
pulisher
Oct 09, 2024

TSVT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 2seventy bio, Inc. and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Oct 09, 2024
pulisher
Sep 27, 2024

BMS and 2seventy bio Axe Trial for Ide-Cel in Newly Diagnosed Multiple Myeloma - CGTLive™

Sep 27, 2024
pulisher
Sep 25, 2024

2seventy bio Provides Update on KarMMa-9 Study and Previews Anticipated Strong Third Quarter Revenue Performance - Business Wire

Sep 25, 2024
pulisher
Sep 24, 2024

Seven Eight Capital LP Makes New $197,000 Investment in Beyond, Inc. (NYSE:BYON) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Q&A: Athens legends Five Eight and the makers of their new documentary film, "Weirdo" - Online Athens

Sep 24, 2024
pulisher
Sep 22, 2024

Four killed, dozens injured in Alabama mass shooting - Daily Sun

Sep 22, 2024
pulisher
Sep 22, 2024

Seven Eight Capital LP Sells 536 Shares of Dell Technologies Inc. (NYSE:DELL) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Four dead, 17 others shot in Birmingham mass shooting - WJLA

Sep 22, 2024
pulisher
Sep 22, 2024

Five Below, Inc. (NASDAQ:FIVE) Stake Raised by Teca Partners LP - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Four killed, over 20 injured in Birmingham, Alabama shooting - Thaiger World

Sep 22, 2024
pulisher
Sep 22, 2024

At least four dead and dozens injured in shootout with multiple assailants in the United States - Top Buzz Times

Sep 22, 2024
pulisher
Sep 22, 2024

Four people dead and dozens injured in US mass shooting horror - Express

Sep 22, 2024
pulisher
Sep 21, 2024

Analyst bullish on Tectonic's TX45 ahead of full trial results presentation at AHA - Investing.com India

Sep 21, 2024
pulisher
Sep 19, 2024

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - GlobeNewswire

Sep 19, 2024
pulisher
Sep 19, 2024

Hedge fund Two Sigma in settlement talks with US SEC, WSJ reports - XM

Sep 19, 2024
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
자본화:     |  볼륨(24시간):